logoCabeceraNinos

Hemos leído sobre ... Uveítis

Última actualización: 15 Noviembre 2018
 
 
 
OCTUBRE 2018
  • Hughes DA, Culeddu G, Plumpton C, Wood E, Dick AD, Jones AP, McKay A, Williamson PR, Compeyrot Lacassagne S, Hardwick B, Hickey H, Woo P, Beresford MW, Ramanan AV.
    Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis
    Ophthalmology. 2018 Oct 15. pii: S0161-6420(18)31146-1. doi: 10.1016/j.ophtha.2018.09.043. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30336181
  • Lee JJY, Duffy CM, Guzman J, Oen K, Barrowman N, Rosenberg AM, Shiff NJ, Boire G, Stringer E, Spiegel L, Morishita KA, Lang B, Reddy D, Huber AM, Cabral DA, Feldman BM, Yeung RSM, Tucker LB, Watanabe Duffy K; ReACCh-Out Investigators.
    Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes Cohort.
    Arthritis Care Res (Hoboken). 2018 Oct 15. doi: 10.1002/acr.23783. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30320957
  • Hissink Muller P, Brinkman DMC, Schonenberg-Meinema D, van den Bosch WB, Koopman-Keemink Y, Brederije ICJ, Bekkering PW, Kuijpers TW, Van Rossum M, van Suijlekom-Smit LW, van den Berg JM, Boehringer S, Allaart CF, Ten Cate R.
    Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial
    Ann Rheum Dis. 2018 Oct 11. pii: annrheumdis-2018-213902. doi: 10.1136/annrheumdis-2018-213902. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30309970
  • Wieringa WG, Armbrust W, Legger GE, Los LI.
    Efficacy of High-Dose Methotrexate in Pediatric Non-Infectious Uveitis
    Ocul Immunol Inflamm. 2018 Oct 22:1-9. doi: 10.1080/09273948.2018.1529800. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30346845
 
SEPTIEMBRE 2018
  • Zygmunt A, Lipińska J, Biernacka-Zielińska M, Lipiec E, Niwald A, Smolewska E
    Comparison of uveitis in the course of juvenile idiopathic arthritis with isolated uveitis in children - own experiences.
    Reumatologia. 2018;56(3):149-154.
    https://www.ncbi.nlm.nih.gov/pubmed/30042602
  • Ruiz-Medrano J, Díaz-Valle D, Cuiña R, Gegúndez JA, Chhablani J, Majumder PD, Gutierrez-Bonet R.
    The role of tocilizumab in the treatment of inflammatory diseases of the eye and orbit: A useful alternative.
    J Fr Ophtalmol. 2018 Sep 11. pii: S0181-5512(18)30282-1. doi: 10.1016/j.jfo.2018.02.006. [Epub ahead of print]

    https://www.ncbi.nlm.nih.gov/pubmed/30217605
  • Multicenter Uveitis Steroid Treatment Trial Research Group; Writing Committee:, Thorne JE, Sugar EA, Holbrook JT, Burke AE, Altaweel MM, Vitale AT, Acharya NR, Kempen JH, Jabs DA.
    Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.
    Ophthalmology. 2018 Sep 20. pii: S0161-6420(18)31133-3. doi: 10.1016/j.ophtha.2018.08.021. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30269924
  • Kulik U, Wiklund A, Kugelberg M, Lundvall A.
    Long-term results after primary intraocular lens implantation in children with juvenile idiopathic arthritis-associated uveitis.
    Eur J Ophthalmol. 2018 Sep 12:1120672118799623. doi: 10.1177/1120672118799623. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30207174
  • Baghdasaryan E, Tepelus TC, Marion KM, Huang J, Huang P, Sadda SR, Lee OL.
    Analysis of ocular inflammation in anterior chamber-involving uveitis using swept-source anterior segment OCT.
    Int Ophthalmol. 2018 Sep 20. doi: 10.1007/s10792-018-1005-0. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30238391
  • Ma S, Rogers SL, Hall AJ, Hodgson L, Brennan J, Stawell R, Lim LL.
    Sarcoidosis related uveitis: Clinical presentations, disease course and rates of systemic disease progression after uveitis diagnosis.
    Am J Ophthalmol. 2018 Sep 20. pii: S0002-9394(18)30532-4. doi: 10.1016/j.ajo.2018.09.013. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30243930
  • Curragh DS, McAvoy CE, Rooney M, McLoone E.
    Post-streptococcal uveitis syndrome in a Caucasian population: a case series.
    Eye (Lond). 2018 Sep 18. doi: 10.1038/s41433-018-0214-0. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30228367
  • Richard Colmant G, Kodjikian L, De Parisot De Bernecourt A, Guillaud M, Gerfaud-Valentin M, Denis P, Broussolle C, Jamilloux Y, Sève P.
    Uveitis of Unknown Etiology: Clinical and Outcome features. A Retrospective Analysis of 355 Patients.
    Ocul Immunol Inflamm. 2018 Sep 20:1-8. doi: 10.1080/09273948.2018.1522356. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30234412
  • Agrawal R, Gunasekeran DV, Agarwal A, Carreño E, Aggarwal K, Gupta B, et al.
    The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Description of the Spectrum of Choroidal Involvement in 245 Patients with Tubercular Uveitis.
    Ocul Immunol Inflamm. 2018 Aug 29:1-11. doi: 10.1080/09273948.2018.1489061. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30156979
  • Teixeira-Lopes F, Alfarroba S, Dinis A, Gomes MC, Tavares A.
    Ocular tuberculosis - A closer look to an increasing reality.
    Pulmonology. 2018 Sep - Oct;24(5):289-293
    https://www.ncbi.nlm.nih.gov/pubmed/30293580
 
AGOSTO 2018
  • Abd El Latif E MD, Fayez Goubran W MD, El Gemai EEDM MD, Habib AE MD, Abdelbaki AM MD, Ammar H MD, Seleet M MD.
    Pattern of Childhood Uveitis in Egypt.
    Ocul Immunol Inflamm. 2018 Aug 27:1-7. doi: 10.1080/09273948.2018.1502325. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30148647
  • Cann M, Ramanan AV, Crawford A, Dick AD, Clarke SLN, Rashed F, Guly CM.
    Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy.
    Pediatr Rheumatol Online J. 2018 Aug 6;16(1):51. doi: 10.1186/s12969-018-0266-5.
    https://www.ncbi.nlm.nih.gov/pubmed/30081917
  • Cecchin V, Zannin ME, Ferrari D, Pontikaki I, Miserocchi E, Paroli MP, Bracaglia C, Marafon DP, Pastore S, Parentin F, Simonini G, De Libero C, Falcini F, Petaccia A, Filocamo G, De Marco R, La Torre F, Guerriero S, Martino S, Comacchio F, Muratore V, Martini G, Vittadello F, Zulian F.
    Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2018 Aug;45(8):1167-1172. doi: 10.3899/jrheum.171006. Epub 2018 Apr 15.
    https://www.ncbi.nlm.nih.gov/pubmed/29657140
  • Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C, Gepstein R, Heiligenhaus A, Pilkington CA, Simonini G, Uziel Y, Vastert SJ, Wulffraat NM, Haasnoot AM, Walscheid K, Pálinkás A, Pattani R, Györgyi Z, Kozma R, Boom V, Ponyi A, Ravelli A, Ramanan AV.
    Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.
    Ann Rheum Dis. 2018 Aug;77(8):1107-1117. doi: 10.1136/annrheumdis-2018-213131. Epub 2018 Mar 28.
    https://www.ncbi.nlm.nih.gov/pubmed/29592918
  • Palmou-Fontana N, Calvo-Río V, Martín-Varillas JL, Fernández-Díaz C, Mesquida M,Adán A, Hernández MV, Cordero-Coma M, Maiz Alonso O, Díaz-Valle D, Fernández-Cid C, Ruiz-Moreno O, Hernández JL, González-Gay MA, Blanco R.
    Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review.
    Clin Exp Rheumatol. 2018 Jul-Aug;36(4):652-657. Epub 2017 Dec 15.
    https://www.ncbi.nlm.nih.gov/pubmed/29303704
 
JULIO 2018
  • Quartier P, Baptiste A, Despert V, Allain-Launay E, Koné-Paut I, Belot A, Kodjikian L, Monnet D, Weber M, Elie C, Bodaghi B, ADJUVITEStudy Group.
    ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis.
    Ann Rheum Dis. 2018 Jul;77(7):1003-1011. doi: 10.1136/annrheumdis-2017-212089. Epub 2017 Dec 23.
    https://www.ncbi.nlm.nih.gov/pubmed/29275333
  • Cann M, Ramanan AV, Crawford A, Dick AD, Clarke SLN, Rashed F, Guly CM.
    Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy.
    Pediatr Rheumatol Online J. 2018 Aug 6;16(1):51. doi: 10.1186/s12969-018-0266-5.
    https://www.ncbi.nlm.nih.gov/pubmed/30081917
  • Palmou-Fontana N, Calvo-Río V, Martín-Varillas JL, Fernández-Díaz C, Mesquida M, Adán A, Hernández MV, Cordero-Coma M, Maiz Alonso O, Díaz-Valle D, Fernández-Cid C, Ruiz-Moreno O, Hernández JL, González-Gay MA, Blanco R.
    Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review.
    Clin Exp Rheumatol. 2018 Jul-Aug;36(4):652-657. Epub 2017 Dec 15.
    https://www.ncbi.nlm.nih.gov/pubmed/29303704
 
JUNIO 2018
  • Souto FMS, Giampietro BV, Takiuti JT, Campos LMA, Hirata CE, Yamamoto JH.
    Clinical features of paediatric uveitis at a tertiary referral centre in São Paulo, SP, Brazil.
    Br J Ophthalmol. 2018 Jun 15. pii: bjophthalmol-2018-312313. doi: 10.1136/bjophthalmol-2018-312313
    https://www.ncbi.nlm.nih.gov/pubmed/29907630
  • Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, Vannozzi L, di Scala G, Guerriero S, Orlando I, Franceschini R, Capozzoli M, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.
    Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumab.
    Clin Rheumatol. 2018 Jun;37(6):1715-1720. doi: 10.1007/s10067-018-4092-4
    https://www.ncbi.nlm.nih.gov/pubmed/29671190
 
MAYO 2018
  • Atienza-Mateo B, Calvo-Río V, Beltrán E, Martínez-Costa L, Valls-Pascual E, Hernández-Garfella M, Atanes A, Cordero-Coma M, Miquel Nolla J, Carrasco-Cubero C, Loricera J, González-Vela MC, Vegas-Revenga N, Fernández-Díaz C, Demetrio-Pablo R, Domínguez-Casas LC, Luis Martín-Varillas J, Palmou-Fontana N, Hernández JL, González-Gay MÁ, Blanco R.
    Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study.
    Rheumatology (Oxford). 2018 May 1;57(5):856-864. doi:10.1093/rheumatology/kex480.
    https://www.ncbi.nlm.nih.gov/pubmed/29471416
  • Angeles-Han ST, Lo MS, Henderson LA, Lerman MA, Abramson L, Cooper AM, Parsa MF, Zemel LS, Ronis T, Beukelman T, Cox E, Sen HN, Holland GN, Brunner HI, Lasky A, Rabinovich CE; Juvenile Idiopathic Arthritis Disease-Specific Uveitis Subcommittee of Childhood Arthritis Rheumatology Research Alliance.
    Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for juvenile idiopathic arthritis-associated and idiopathic chronic anterior uveitis.
    Arthritis Care Res (Hoboken). 2018 May 28. doi: 10.1002/acr.23610. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29806733
  •  Rosenbaum JT, Dick AD.
    The Eyes Have It: A Rheumatologist's View of Uveitis.
    Arthritis Rheumatol. 2018 May 23. doi: 10.1002/art.40568. [Epub ahead of print] Review.
    https://www.ncbi.nlm.nih.gov/pubmed/29790291
  • Walscheid K, Neekamp L, Heiligenhaus A, Weinhage T, Heinz C, Foell D.
    Increased Circulating Proinflammatory T Lymphocytes in Children with Different Forms of Anterior Uveitis: Results from a Pilot Study.
    Ocul Immunol Inflamm. 2018 May 17:1-10. doi: 10.1080/09273948.2018.1467464. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29771573
 
ABRIL 2018
  • Bauer D, Kasper M, Walscheid K, Koch JM, Müther PS, Kirchhof B, Heiligenhaus A, Heinz C.
    Multiplex Cytokine Analysis of Aqueous Humor in Juvenile Idiopathic Arthritis-AssociatedAnterior Uveitis With or Without Secondary Glaucoma.
    Front Immunol. 2018 Apr 5;9:708. doi: 10.3389/fimmu.2018.00708. eCollection 2018.
    https://www.ncbi.nlm.nih.gov/pubmed/29675026
  • Cecchin V, Zannin ME, Ferrari D, Pontikaki I, Miserocchi E, Paroli MP, Bracaglia C, Marafon DP, Pastore S, Parentin F, Simonini G, De Libero C, Falcini F, Petaccia A, Filocamo G, De Marco R, La Torre F, Guerriero S, Martino S, Comacchio F, Muratore V, Martini G, Vittadello F, Zulian F.
    Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2018 Apr 15. pii: jrheum.171006. doi: 10.3899/jrheum.171006. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29657140
  • Leinonen S, Immonen I, Kotaniemi K.
    Fluocinolone acetonide intravitreal implant (Retisert® ) in the treatment of sight threatening macular oedema of juvenile idiopathic arthritis-related uveitis.
    Acta Ophthalmol. 2018 Apr 14. doi: 10.1111/aos.13744. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29655222
  • Deitch I, Amer R, Tomkins-Netzer O, Habot-Wilner Z, Friling R, Neumann R, Kramer M.
    The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies.
    Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):801-808. doi: 10.1007/s00417-018-3928-6. Epub 2018 Feb 18.
    https://www.ncbi.nlm.nih.gov/pubmed/29455252
  • Fabiani C, Vitale A, Emmi G, Bitossi A, Lopalco G, Sota J, Guerriero S, Orlando I, Capozzoli M, Fusco F, Rana F, Iannone F, Frediani B, Galeazzi M, Vannozzi L, Tosi GM, Cantarini L.
    Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis.
    Clin Rheumatol. 2018 Apr 3. doi: 10.1007/s10067-018-4069-3. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29611087
 
MARZO 2018
  • Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C, Gepstein R, Heiligenhaus A, Pilkington CA, Simonini G, Uziel Y, Vastert SJ, Wulffraat NM, Haasnoot AM, Walscheid K, Pálinkás A, Pattani R, Györgyi Z, Kozma R, Boom V, Ponyi A, Ravelli A, Ramanan AV.
    Consensus-based recommendations for the management of uveitis associated with juvenileidiopathic arthritis: the SHARE initiative.
    Ann Rheum Dis. 2018 Mar 28. pii: annrheumdis-2018-213131. doi: 10.1136/annrheumdis-2018-213131. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29592918
  • Haasnoot AJW, Schilham MW, Kamphuis S, Hissink Muller PCE, Heiligenhaus A, Foell D, Minden K, Ophoff RA, Radstake TRDJ, Den Hollander AI, Reinards THCM, Hiddingh S, Schalij-Delfos NE, Hoppenreijs EPAH, van Rossum MAJ, Wouters C, Saurenmann RK, van den Berg JM, Wulffraat NM, Ten Cate R, de Boer JH, Pulit SL, Kuiper JJW.
    An amino acid motif in HLA-DRβ1 distinguishes patients with uveitis in juvenile idiopathic arthritis.
    Arthritis Rheumatol. 2018 Mar 7. doi: 10.1002/art.40484. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29513936
  • Acharya NR, Patel S, Homayounfar G, Enanoria WTA, Shakoor A, Chakrabarti A, Goldstein DA.
    Relapse of Juvenile Idiopathic Arthritis-Associated Uveitis after Discontinuation of Immunomodulatory Therapy.
    Ocul Immunol Inflamm. 2018 Feb 16:1-7. doi: 10.1080/09273948.2018.1424341. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29451845
  • Ramanan AV, Guly C.
    Adalimumab for childhood onset uveitis.
    Ann Rheum Dis. 2018 Feb 28. pii: annrheumdis-2017-212767. doi: 10.1136/annrheumdis-2017-212767. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29490981
  • Dawson V, Dao D, Leu M, Egense Mgc A, Jinadu L, Malone L, Alexander J.
    Tubulointerstitial nephritis and uveitis (TINU) with granulomatosis: a novel report of simultaneous TINU and sarcoidosis in a pediatric patient.
    J AAPOS. 2018 Mar 31. pii: S1091-8531(17)31040-6. doi: 10.1016/j.jaapos.2018.02.004. [Epub ahead of print]  https://www.ncbi.nlm.nih.gov/pubmed/29614344
  • Martín-Varillas JL, Calvo-Río V, Beltrán E, Sánchez-Bursón J, Mesquida M, Adán A, Hernandez MV, Garfella MH, Pascual EV, Martínez-Costa L, Sellas-Fernández A, Cordero-Coma M, Díaz-Llopis M, et al.
    Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease.
    Ophthalmology. 2018 Mar 27. pii: S0161-6420(17)33390-0. doi: 10.1016/j.ophtha.2018.02.020. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29602570
 
FEBRERO 2018
  • Acharya NR, Patel S, Homayounfar G, Enanoria WTA, Shakoor A, Chakrabarti A, Goldstein DA.
    Relapse of Juvenile Idiopathic Arthritis-Associated Uveitis after Discontinuation of Immunomodulatory Therapy
    Ocul Immunol Inflamm. 2018 Feb 16:1-7. doi: 10.1080/09273948.2018.1424341
    https://www.ncbi.nlm.nih.gov/pubmed/29451845
 
ENERO 2018
  • Ferrara M, Eggenschwiler L, Stephenson A, Montieth A, Nakhoul N, Araùjo-Miranda R, Foster CS.
    The Challenge of Pediatric Uveitis: Tertiary Referral Center Experience in the United States.
    Ocul Immunol Inflamm. 2018 Jan 15:1-8. doi: 10.1080/09273948.2017.1420202. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29333911

 
DICIEMBRE 2017
  • Quartier P, Baptiste A, Despert V, Allain-Launay E, Koné-Paut I, Belot A, Kodjikian L, Monnet D, Weber M, Elie C, Bodaghi B; ADJUVITE Study Group.
    ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis.
    Ann Rheum Dis. 2017 Dec 23. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29275333
  • Leinonen ST, Aalto K, Kotaniemi KM, Kivelä TT.
    Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis.
    Clin Exp Rheumatol. 2017 Nov-Dec;35(6):1043-1046.
    https://www.ncbi.nlm.nih.gov/pubmed/29148422

  • Haasnoot AJW, Sint Jago NFM, Tekstra J, de Boer JH.
    Impact of Uveitis on Quality of Life in Adult Patients With Juvenile Idiopathic Arthritis.
    Arthritis Care Res (Hoboken). 2017 Dec;69(12):1895-1902.
    https://www.ncbi.nlm.nih.gov/pubmed/28217950
  • Palmou-Fontana N, Calvo-Río V, Martín-Varillas JL, Fernández-Díaz C, Mesquida M, Adán A, Hernández MV, Cordero-Coma M, Maiz Alonso O, Díaz-Valle D, Fernández-Cid C, Ruiz-Moreno O, Hernández JL, González-Gay MA, Blanco R.
    Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review.
    Clin Exp Rheumatol. 2017 Dec 15. [Epub ahead of print] Review.
    https://www.ncbi.nlm.nih.gov/pubmed/29303704
  • Borrego-Sanz L, Abásolo L, López-Abad C, Fernández-Gutiérrez B, García-Feijoo J, Diaz-Valle D, Pato E, Rodriguez-Rodriguez L.
    Disease Remission in Children and Adolescents with Intermediate Uveitis: A Survival Analysis.
    Ophthalmologica. 2017 Dec 14. doi: 10.1159/000485262. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29241207
 
NOVIEMBRE 2017
  • Fabiani C, Sota J, Vitale A, Emmi G, Vannozzi L, Bacherini D, Lopalco G, Guerriero S, Venerito V, Orlando I, Franceschini R, Fusco F, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.
    Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis.
    Ocul Immunol Inflamm. 2017 Nov 3
    https://www.ncbi.nlm.nih.gov/pubmed/29099660
  • Papadopoulou M, Zetterberg M, Oskarsdottir S, Andersson Grönlund M.
    Assessment of the outcome of ophthalmological screening for uveitis in a cohort of Swedish children with juvenile idiopathic arthritis.
    Acta Ophthalmol. 2017 Nov;95(7):741-747
    https://www.ncbi.nlm.nih.gov/pubmed/28205413
  • Salek SS, Pradeep A, Guly C, Ramanan AV, Rosenbaum JT.
    Uveitis and Juvenile Psoriatic Arthritis or Psoriasis.
    Am J Ophthalmol. 2017 Oct 31
    https://www.ncbi.nlm.nih.gov/pubmed/29101009
  • Leinonen ST, Aalto K, Kotaniemi KM, Kivelä TT.
    Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis.
    Clin Exp Rheumatol. 2017 Nov 14
    https://www.ncbi.nlm.nih.gov/pubmed/29148422
 
OCTUBRE 2017
  • Kolomeyer AM, Crane ES, Tu Y, Liu D, Chu DS.
    Adult patients with uveitis associated with juvenile idiopathic arthritis: a retrospective review.
    Can J Ophthalmol. 2017 Oct;52(5):458-462. doi: 10.1016/j.jcjo.2017.01.011.
    https://www.ncbi.nlm.nih.gov/pubmed/28985804
  • Fabiani C, Sota J, Rigante D, Vitale A, Emmi G, Vannozzi L, Franceschini R, Bacherini D, Frediani B, Galeazzi M, Tosi GM, Cantarini L.
    Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet's Disease.
    Ocul Immunol Inflamm. 2017 Oct 5:1-6. doi: 10.1080/09273948.2017.1351573.
    https://www.ncbi.nlm.nih.gov/pubmed/28981395
 
SEPTIEMBRE 2017
  • Sarens IL, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Dick AD, Espada G, Fernandez-Martin J, Guly CM, Hachulla E, Harjacek M, Khubchandani R, Mackensen F, Merino R, Modesto C, Naranjo A, Oliveira-Knupp S, Özen S, Pajot C, Ramanan AV, Russo R, Susic G, Thatayatikom A, Thomée C, Vastert S, Bertin J, Arostegui JI, Rose CD, Wouters CH.
    Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series.
    Am J Ophthalmol. 2017 Sep 6. pii: S0002-9394(17)30371-9. doi: 10.1016/j.ajo.2017.08.017. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28887115
  • Crowell EL, Bahr AK, Adesina OO, Kamdar AA, Kumar KS, Goldberg A.
    Orbital Inflammatory Syndrome and Anterior Uveitis: A Case Series.
    Ocul Immunol Inflamm. 2017 Sep 29:1-6. doi: 10.1080/09273948.2017.1349156. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28961042
 
AGOSTO 2017
  • Takkar B, Venkatesh P, Gaur N, Garg SP, Vohra R, Ghose S.
    Patterns of uveitis in children at the apex institute for eye care in India: analysis and review of literature.
    Int Ophthalmol. 2017 Aug 31. doi: 10.1007/s10792-017-0700-6. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28861733
  • Peng S, Sun X, Sun M.
    Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.
    N Engl J Med. 2017 Aug 24;377(8):789. doi: 10.1056/NEJMc1708646.
    https://www.ncbi.nlm.nih.gov/pubmed/28836421
  • Nordal E, Rypdal V, Christoffersen T, Aalto K, Berntson L, Fasth A, Herlin T, Nielsen S, Peltoniemi S, Straume B, Zak M, Rygg M; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
    Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study.
    Pediatr Rheumatol Online J. 2017 Aug 18;15(1):66. doi: 10.1186/s12969-017-0195-8.
    https://www.ncbi.nlm.nih.gov/pubmed/28821293
  • Sen ES, Morgan MJ, MacLeod R, Strike H, Hinchcliffe A, Dick AD, Muthusamy B, Ramanan AV.
    Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis.
    Pediatr Rheumatol Online J. 2017 Aug 4;15(1):58. doi: 10.1186/s12969-017-0189-6.
    https://www.ncbi.nlm.nih.gov/pubmed/28778202

 

JULIO 2017
  • Sardar E, Dusser P, Rousseau A, Bodaghi B, Labetoulle M, Koné-Paut I.
    Retrospective Study Evaluating Treatment Decisions and Outcomes of Childhood Uveitis Not Associated with Juvenile Idiopathic Arthritis.
    J Pediatr. 2017 Jul;186:131-137.e1. doi: 10.1016/j.jpeds.2017.03.052. Epub 2017 Apr 27.
    https://www.ncbi.nlm.nih.gov/pubmed/28457525
  • Sota J, Rigante D, Lopalco G, Frediani B, Franceschini R, Galeazzi M, Iannone F, Tosi GM, Fabiani C, Cantarini L.
    Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.
    Rheumatol Int. 2017 Jul 27. doi: 10.1007/s00296-017-3775-5. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28752230
 
JUNIO 2017
  • Rosenbaum JT.
    New developments in uveitis associated with HLA B27.
    Curr Opin Rheumatol. 2017 Jul;29(4):298-303.
    https://www.ncbi.nlm.nih.gov/pubmed/28376061
  • Simonini G, Bracaglia C, Cattalini M, Taddio A, Brambilla A, De Libero C, Pires Marafon D, Caputo R, Cimaz R.
    Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.
    J Rheumatol. 2017 Jun;44(6):822-826.
    https://www.ncbi.nlm.nih.gov/pubmed/28365583
  • Muñoz-Gallego A, Barral E, Enríquez E, Tejada P, Barceló A, de Inocencio J.
    Adalimumab for the treatment of refractory noninfectious paediatric uveitis.
    Int Ophthalmol. 2017 Jun;37(3):719-725.
    https://www.ncbi.nlm.nih.gov/pubmed/27432171
 
MAYO 2017
  • Lopalco G, Fabiani C, Sota J, Lucherini OM, Tosi GM, Frediani B, Iannone F, Galeazzi M, Franceschini R, Rigante D, Cantarini L.
    IL-6 blockade in the management of non-infectious uveitis.
    Clin Rheumatol. 2017 May 20. [Epub ahead of print]
 
ABRIL 2017
  • Berker N, Sen E, Elgin U, Atilgan CU, Dursun E, Yilmazbas P.
    Analysis of clinical features and visual outcomes of pars planitis
    Int Ophthalmol. 2017 Apr 7. doi: 10.1007/s10792-017-0526-2. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28389773
MARZO 2017
  • Simonini G, Bracaglia C, Cattalini M, Taddio A, Brambilla A, De Libero C, Pires Marafon D, Caputo R, Cimaz R.
    Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.
    J Rheumatol. 2017 Apr 1. pii: jrheum.161336. doi: 10.3899/jrheum.161336. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28365583
  • Rosenbaum JT.
    New developments in uveitis associated with HLA B27.
    Curr Opin Rheumatol. 2017 Apr 3. doi: 10.1097/BOR.0000000000000403. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28376061
FEBRERO 2017
  • Haasnoot AJ, Sint Jago NF, Tekstra J, de Boer JH1.
    Impact of uveitis on Quality of Life in Adult patients with Juvenile Idiopathic Arthritis.
    Arthritis Care Res (Hoboken). 2017 Feb 19. doi: 10.1002/acr.23224. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28217950
  • Papadopoulou M, Zetterberg M,, Oskarsdottir S, Andersson Grönlund M.
    Assessment of the outcome of ophthalmological screening for uveitis in a cohort of Swedish children with juvenile idiopathic arthritis.
    Acta Ophthalmol. 2017 Feb 15. doi: 10.1111/aos.13388. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28205413
  • Quesada-Masachs E, Caballero CM.
    Subcutaneous Tocilizumab May Be Less Effective than Intravenous Tocilizumab in the Treatment of Juvenile Idiopathic Arthritis-associated Uveitis.
    J Rheumatol. 2017 Feb;44(2):260-261. doi: 10.3899/jrheum.160908.
    https://www.ncbi.nlm.nih.gov/pubmed/28148759
  • Kahwage PP, Ferriani MP, Furtado JM, de Carvalho LM, Pileggi GS, Gomes FH, Terreri MT, Magalhães CS, Pereira RM, Sacchetti SB, Marini R, Bonfá E, Silva CA, Ferriani VP.
    Uveitis in childhood-onset systemic lupus erythematosus patients: a multicenter survey.
    Clin Rheumatol. 2017 Mar;36(3):547-553. doi: 10.1007/s10067-016-3534-0. Epub 2017 Jan 9.
    https://www.ncbi.nlm.nih.gov/pubmed/28070763
ENERO 2017
 
DICIEMBRE 2016
  • Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.
    Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2016 Dec;43(12):2183-2188.
    https://www.ncbi.nlm.nih.gov/pubmed/27633821
 
NOVIEMBRE 2016
  • Pato E, Martin-Martinez MA, Castelló A, Méndez-Fernandez R, Muñoz-Fernández S, Cordero-Coma M, Martinez-Costa L, Valls E, Reyes M, Francisco F, Esteban M, Fonollosa A, Sanchez-Alonso F, Fernández-Espartero C, Diaz-Valle T, Carrasco JM, Beltran-Catalán E, Hernández-Garfella M, Hernández MV, Pelegrin L, Blanco R, Diaz-Valle D.
    Development of an activity disease score in patients with uveitis (UVEDAI).
    Rheumatol Int. 2016 Nov 4.
    https://www.ncbi.nlm.nih.gov/pubmed/27815703
  • Birolo C, Zannin ME, Arsenyeva S, Cimaz R, Miserocchi E, Dubko M, Deslandre CJ, Falcini F, Alessio M, La Torre F, Denisova E, Martini G, Nikishina I, Zulian F.
    Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.
    J Rheumatol. 2016 Nov;43(11):2068-2073.
    https://www.ncbi.nlm.nih.gov/pubmed/27633826
 
SEPTIEMBRE 2016
  • Breitbach M, Tappeiner C, Böhm MR, Zurek-Imhoff B, Heinz C, Thanos S, Ganser G, Heiligenhaus A.
    Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis.
    Graefes Arch Clin Exp Ophthalmol. 2016 Sep 30.
    https://www.ncbi.nlm.nih.gov/pubmed/27687987
  • Balevic SJ, Rabinovich CE.
    Drug Des Devel Ther. 2016 Sep 19;10:2997-3003.
    Profile of adalimumab and its potential in the treatment of uveitis.
    https://www.ncbi.nlm.nih.gov/pubmed/27698552
  • Haasnoot AJ, Vernie LA, Rothova A, V D Doe P, Los LI, Schalij-Delfos NE, de Boer JH.
    Impact of Juvenile Idiopathic Arthritis Associated Uveitis in Early Adulthood.
    PLoS One. 2016 Oct 10;11(10):e0164312.
    https://www.ncbi.nlm.nih.gov/pubmed/27723840
  • Calvo-Río V, Santos-Gómez M, Calvo I, González-Fernández MI, López Montesinos B, Mesquida M, Adán A, Victoria Hernández M, Maíz O, Atanes A, Bravo B, Modesto C, Díaz-Cordovés G, Palmou-Fontana N, Loricera J, González-Vela MC, Demetrio-Pablo R, Hernández JL, González-Gay MA, Blanco R.
    Anti-IL6-R Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to anti-TNF therapy. A multicenter study of 25 patients.
    Arthritis Rheumatol. 2016 Oct 1.
    https://www.ncbi.nlm.nih.gov/pubmed/27696756
  • Böhm MR, Tappeiner C, Breitbach MA, Zurek-Imhoff B, Heinz C, Heiligenhaus A.
    Ocular hypotony in patients with juvenile idiopathic arthritis - associated uveitis.
    Am J Ophthalmol. 2016 Sep 21.
    https://www.ncbi.nlm.nih.gov/pubmed/27664701
  • Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.
    Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2016 Sep 15.
    https://www.ncbi.nlm.nih.gov/pubmed/27633821
  • Moradi A, Stroh IG, Reddy AK, Hornbeak DM, Leung TG, Burkholder BM, Thorne JE.
    Risk of Hypotony in Juvenile Idiopathic Arthritis-Associated Uveitis.
    Am J Ophthalmol. 2016 Sep;169:113-24.
    https://www.ncbi.nlm.nih.gov/pubmed/27345732
 
AGOSTO 2016
  • Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.
    Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2016 Sep 15. pii: jrheum.160231. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27633821
  • Birolo C, Zannin ME, Arsenyeva S, Cimaz R, Miserocchi E, Dubko M, Deslandre CJ, Falcini F, Alessio M, La Torre F, Denisova E, Martini G, Nikishina I, Zulian F.
    Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.
    J Rheumatol. 2016 Sep 15. pii: jrheum.151389. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27633826
  • Guindolet D, Dureau P, Terrada C, Edelson C, Barjol A, Caputo G, LeHoang P, Bodaghi B.
    Cataract Surgery with Primary Lens Implantation in Children with Chronic Uveitis.
    Ocul Immunol Inflamm. 2016 Sep 6:1-7. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27599095   
  • Paovic J, Paovic P, Sredovic V, Jovanovic S
    Clinical Manifestations, Complications and Treatment of Ocular Sarcoidosis: Correlation between Visual Efficiency and Macular Edema as Seen on Optical Coherence Tomography.
    Semin Ophthalmol. 2016 Sep 14:1-8. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27628176
 
JULIO 2016
  • Haasnoot AM, Kuiper JJ, Hiddingh S, Schellekens PA, de Jager W, Imhof SM, Radstake TR, de Boer JH.
    Ocular Fluid Analysis in Children Reveals Interleukin-29/Interferon-λ1 as a Biomarker for Juvenile Idiopathic Arthritis-Associated Uveitis.
    Arthritis Rheumatol. 2016 Jul;68(7):1769-79. doi: 10.1002/art.39621.
    http://www.ncbi.nlm.nih.gov/pubmed/26866822
  • Muñoz-Gallego A, Barral E, Enríquez E, Tejada P, Barceló A, de Inocencio J
    Adalimumab for the treatment of refractory noninfectious paediatric uveitis.
    Int Ophthalmol. 2016 Jul 18. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27432171 
  • Kostik MM, Gaidar EV, Hynnes AY, Dubko MF, Masalova VV, Snegireva LS, Chikova IA, Isupova EA, Nikitina TN, Serogodskaya ED, Kalashnikova OV, Ravelli A, Chasnyk VG.
    Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
    Clin Exp Rheumatol. 2016 Jul-Aug;34(4):714-8. Epub 2016 Jun 22.
    http://www.ncbi.nlm.nih.gov/pubmed/27385618
 
JUNIO 2016
 
MAYO 2016
 
ABRIL 2016
 
MARZO 2016
  • Vallet H, Seve P, Biard L, Baptiste Fraison J, Bielefeld P, Perard L, et al; french uveitis network.
    Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: Multicenter study from the french uveitis network.
    Arthritis Rheumatol. 2016 Mar 25. doi: 10.1002/art.39667. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27015607
  • Silpa-Archa S, Oray M, Preble JM, Foster CS.
    Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.
    Acta Ophthalmol. 2016 Mar 24. doi: 10.1111/aos.13015. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27010181
  • Stroh IG, Moradi A, Burkholder BM, Hornbeak DM, Leung TG, Thorne JE.
    Occurrence of and Risk Factors for Ocular Hypertension and Secondary Glaucoma inJuvenile Idiopathic Arthritis-associated Uveitis.
    Ocul Immunol Inflamm. 2016 Mar 22:1-10. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27003850
  • Verhagen FH, Brouwer AH, Kuiper JJ, Ossewaarde-van Norel J, Ten Dam-van Loon NH, de Boer JH.
    Potential Predictors of Poor Visual Outcome in Human Leukocyte Antigen-B27-Associated Uveitis.
    Am J Ophthalmol. 2016 Mar 3. pii: S0002-9394(16)30074-5. doi: 10.1016/j.ajo.2016.02.024. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26940162
  • Yeo TH, Ilangovan S, Keane PA, Pavesio C, Agrawal R.
    Discrepancies in assessing anterior chamber activity among uveitis specialists.
    Jpn J Ophthalmol. 2016 Mar 28. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27020454
  • Rosenbaum JT, Lin P, Asquith M.
    Does the Microbiome Cause B27-related Acute Anterior Uveitis?
    Ocul Immunol Inflamm. 2016 Mar 22:1-5. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27002532
  • Phatak S, Lowder C, Pavesio C.
    Controversies in intraocular lens implantation in pediatric uveitis.
    J Ophthalmic Inflamm Infect. 2016 Dec;6(1):12. doi: 10.1186/s12348-016-0079-
    http://www.ncbi.nlm.nih.gov/pubmed/27009616
  • Abásolo L, Prieto-García Á, Díaz-Valle D, Benítez-Del-Castillo JM, Pato E, García-Feijoo J, Fernández-Gutiérrez B, Rodriguez-Rodriguez L
    Influence of baseline demographic and clinical characteristics in the visual outcome of intermediate uveitis: a survival analysis.
    Br J Ophthalmol. 2016 Mar 30. pii: bjophthalmol-2015-307774. doi: 10.1136/bjophthalmol-2015-307774. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27030281
  • Lavezzo MM, Sakata VM, Morita C, Rodriguez EE, Abdallah SF, da Silva FT, Hirata CE, Yamamoto JH.
    Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes.
    Orphanet J Rare Dis. 2016 Mar 24;11(1):29. doi: 10.1186/s13023-016-0412-4.
    http://www.ncbi.nlm.nih.gov/pubmed/27008848
  • Nobre-Cardoso J, Champion E, Darugar A, Fel A, Lehoang P, Bodaghi B.
    Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.
    Ocul Immunol Inflamm. 2016 Mar 22:1-8. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27003221
 
FEBRERO 2016
  • Henderson LA, Zurakowski D, Angeles-Han ST, Lasky A, Rabinovich CE, Lo MS; CARRA Registry Investigators.
    Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry.
    Pediatr Rheumatol Online J. 2016 Feb 16;14(1):9. doi: 10.1186/s12969-016-0069-5.
    http://www.ncbi.nlm.nih.gov/pubmed/26879972
  • Kolomeyer AM, Tu Y, Miserocchi E, Ranjan M, Davidow A, Chu DS.
    Chronic Non-infectious Uveitis in Patients with Juvenile Idiopathic Arthritis.
    Ocul Immunol Inflamm. 2016 Feb 22:1-9. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26902465
  • Haasnoot AJ, Kuiper JJ, Hiddingh S, Schellekens PA, de Jager W2, Imhof SM, Radstake TR, de Boer JH.
    Ocular fluid analysis in children reveals interleukin-29/interferon-λ1 as a biomarker for juvenile idiopathic arthritis associated uveitis.
    Arthritis Rheumatol. 2016 Feb 11. doi: 10.1002/art.39621. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26866822
  • Amin RM, Miserocchi E, Thorne JE, Hornbeak D, Jabs DA, Zierhut M.
    Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis.
    Ocul Immunol Inflamm. 2016 Feb;24(1):81-90. doi: 10.3109/09273948.2015.1077976. Epub 2015 Dec 11.
    http://www.ncbi.nlm.nih.gov/pubmed/26652068
  • Grixti A, Hagan R, Nayak H, Chandna A.
    Multifocal choroiditis with panuveitis in an 8-year-old boy with long standing idiopathic acute anterior uveitis.
    Eur J Ophthalmol. 2016 Feb 29:0. doi: 10.5301/ejo.5000772. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26951535
 
ENERO 2016
  • Tappeiner C, Schenck S, Niewerth M, Heiligenhaus A, Minden K, Klotsche J.
    Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.
    Arthritis Care Res (Hoboken). 2016 Jan;68(1):46-54. doi: 10.1002/acr.22649.
    http://onlinelibrary.wiley.com/doi/10.1002/acr.22649/abstract
 
DICIEMBRE 2015
  • Tappeiner C, Klotsche J, Schenck S, Niewerth M, Minden K, Heiligenhaus A.
    Temporal change in prevalence and complications of uveitis associated with juvenile idiopathic arthritis:data from a cross-sectional analysis of a prospective nationwide study.

    Clin Exp Rheumatol. 2015 Nov-Dec;33(6):936-44.
    http://www.ncbi.nlm.nih.gov/pubmed/26517055
 
NOVIEMBRE 2015
  • Sheila T. Angeles-Han, Steven Yeh, Courtney McCracken, Kirsten Jenkins, Daneka Stryker, Erica Myoung, Larry B. Vogler, Kelly Rouster-Stevens, Scott R. Lambert, Melanie J. Harrison, Sampath Prahalad and Carolyn Drews-Botsch
    Using the Effects of Youngsters’ Eyesight on Quality of Life Questionnaire to Measure Visual Outcomes in Children With Uveitis (pages 1513–1520)

    Arthritis Care & Research DOI: 10.1002/acr.22627
    Abstract
  • Ivan Foeldvari, Ingrid Becker and Gerd Horneff
    Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry (pages 1529–1535)
    Arthritis Care & Research
    DOI: 10.1002/acr.22613
    Abstract
 
OCTUBRE 2015
  • Haroon M, O'Rourke M, Ramasamy P, Murphy CC, FitzGerald O.
    A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool)
    Ann Rheum Dis 2015;74:1990-5.
    http://ard.bmj.com/content/74/11/1990.abstract 
  • Gupta A, Ramanan AV
    Uveitis in Children: Diagnosis and Management.
    Indian J Pediatr. 2015 Sep 30. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26420255
  • Angeles-Han ST, McCracken C, Yeh S, Jang SR, Jenkins K, Cope S, Bohnsack J, Hersh A, Thompson SD, Prahalad S
    HLA Associations in a Cohort of Children With Juvenile Idiopathic Arthritis With and Without Uveitis
    Invest Ophthalmol Vis Sci. 2015 Sep 1;56(10):6043-8. doi: 10.1167/iovs.15-17168.
    http://www.ncbi.nlm.nih.gov/pubmed/26393471
 
SEPTIEMBRE 2015
  • Simonini G, Cimaz R, Jones GT, Macfarlane GJ.
    Non-anti-TNF biologic modifier drugs in non-infectious refractory chronic uveitis: The current evidence from a systematic review.
    Semin Arthritis Rheum. 2015 Oct;45(2):238-50. doi: 10.1016/j.semarthrit.2015.05.006
    http://www.ncbi.nlm.nih.gov/pubmed/26164255
  • Miserocchi E, Modorati G, Berchicci L, Pontikaki I, Meroni P, Gerloni V.
    Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis.
    Br J Ophthalmol. 2015 Sep 22. pii: bjophthalmol-2015-306790. doi: 10.1136/bjophthalmol-2015-306790. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26396026
 
AGOSTO 2015
  • Angeles-Han ST, McCracken C, Yeh S, Jenkins K, Stryker D, Travers C, Rouster-Stevens K, Vogler LB, Lambert SR, Drews-Botsch C, Prahalad S.
    The Association of Race with Childhood Uveitis.
    Am J Ophthalmol. 2015 Aug 6. pii:S0002-9394(15)00463-8. doi: 10.1016/j.ajo.2015.08.002. EPUB ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26255577  
  • Liang F, Terrada C, Ducos de Lahitte G, Quartier P, Lehoang P, Thorne JE, Bodaghi B.
    Foveal Serous Retinal Detachment in Juvenile Idiopathic Arthritis-associated Uveitis.
    Ocul Immunol Inflamm. 2015 Aug 19:1-6. EPUB ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26171661  
  • Marrani E, Paganelli V, de Libero C, Cimaz R, Simonini G.
    Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series.
    Graefes Arch Clin Exp Ophthalmol. 2015 Aug 27. EPUB ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26311261  
 
JULIO 2015
  • Tappeiner C, Schenck S, Niewerth M, Heiligenhaus A, Minden K, Klotsche J
    Impact of anti-inflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: Longitudinal analysis from a nation-wide paediatric rheumatological database.
    Arthritis Care Res (Hoboken). 2015 Jul 20. doi: 10.1002/acr.22649. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26212111
 
JUNIO 2015
  • de Groot-Mijnes JD, Dekkers J, de Visser L, Rothova A, van Loon AM, de Boer JH.
    Antibody Production against B19 Virus in Ocular Fluid of JIA-Associated Uveitis Patients.
    Ophthalmology. 2015 Jun;122(6):1270-1272.e1. doi: 10.1016/j.ophtha.2015.01.006.
    http://www.ncbi.nlm.nih.gov/pubmed/25704320
  •  Rosenbaum JT.
    Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease.
    Clin Rheumatol. 2015 Jun;34(6):999-1002. doi: 10.1007/s10067-015-2960-8.
    http://www.ncbi.nlm.nih.gov/pubmed/25953065
  •  Angeles-Han ST, McCracken C, Yeh S, Jenkins K, Stryker D, Rouster-Stevens K, Vogler LB, Lambert SR et al.
    Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis
    Pediatr Rheumatol Online J. 2015 Jun 2;13:19. doi: 10.1186/s12969-015-0018-8.
    http://www.ncbi.nlm.nih.gov/pubmed/26031738
  •  Sen ES, Dick AD, Ramanan AV.
    Uveitis associated with juvenile idiopathic arthritis.
    Nat Rev Rheumatol. 2015 Jun;11(6):338-348. doi: 10.1038/nrrheum.2015.20.
    http://www.ncbi.nlm.nih.gov/pubmed/25825278
 
MAYO 2015
 
ABRIL 2015
  • Klotsche J, Niewerth M, Haas JP, Huppertz HI, Zink A, Horneff G, Minden K.
    Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
    Ann Rheum Dis. 2015 Apr 29. pii: annrheumdis-2014-206747. doi: 10.1136/annrheumdis-annrheumdis-2014-206747. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25926155  
  • Lerman MA, Rabinovich CE.
    The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.

    Paediatr Drugs. 2015 Apr 17. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25893479
 
MARZO 2015
  • Sen ES, Dick AD, Ramanan AV.
    Uveitis associated with juvenile idiopathic arthritis.
    Nat Rev Rheumatol. 2015 Mar 31. doi: 10.1038/nrrheum.2015.20. [Epub ahead of print] Review.
    http://www.ncbi.nlm.nih.gov/pubmed/25825278
 
FEBRERO 2015
  • Heiligenhaus, A; Minden, K; Föll, D; Pleyer, U
    Uveitis in juvenile idiopathic arthritis.
    Dtsch Arztebl Int. 2015 Feb 6;112(6):92-100.
    http://www.ncbi.nlm.nih.gov/pubmed/25721436
  • Bou R, Adán A, Borrás F, Bravo B, Calvo I, De Inocencio J, Díaz J, Escudero J, Fonollosa A, de Vicuña CG, Hernández V, Merino R, Peralta J, Rúa MJ, Tejada P, Antón J.
    Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus.
    Rheumatol Int. 2015 Feb 6.
    http://www.ncbi.nlm.nih.gov/pubmed/25656443
  • Tappeiner C, Miserocchi E, Bodaghi B, Kotaniemi K, Mackensen F, Gerloni V, Quartier P, Lutz T, Heiligenhaus A.
    Abatacept in the Treatment of Severe, Longstanding, and Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2015 Feb 1.
    http://www.ncbi.nlm.nih.gov/pubmed/25641892
  • Haasnoot AJ, van Tent-Hoeve M, Wulffraat NM, Schalij-Delfos NE, Los LI, Armbrust W, Zuithoff NP, de Boer JH.
    Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis.
    Am J Ophthalmol. 2015 Feb;159(2):372-7.
    http://www.ncbi.nlm.nih.gov/pubmed/25447121
 
ENERO 2015
  • Christoph Tappeiner, Elisabetta Miserocchi, Bahram Bodaghi, Kaisu Kotaniemi, Friederike Mackensen, Valeria Gerloni, Pierre Quartier, Thomas Lutz and Arnd Heiligenhaus
    Abatacept in the Treatment of Severe, Longstanding, and Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
    J Rheumatol published online before print February 1, 2015,doi:10.3899/jrheum.140410
    http://www.jrheum.org/content/early/2015/01/27/jrheum.140410.abstract
 
DICIEMBRE 2014
 
NOVIEMBRE 2014
  • Hettinga YM, Verhagen FH, van Genderen M, de Boer JH.
    Characteristics of childhood uveitis leading to visual impairment and blindness in the Netherlands.
    Acta Ophthalmol. 2014 Dec;92(8):798-804.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=24975684
 
OCTUBRE 2014
  • Langner-Wegscheider BJ, de Smet MD
    Surgical Management of Severe Complications Arising from Uveitis in Juvenile Idiopathic Arthritis
    Ophthalmologica. 2014 Oct 18. [Epub ahead of print]
 
SEPTIEMBRE 2014
  • Kalinina Ayuso V, Makhotkina N, van Tent-Hoeve M, de Groot-Mijnes JD, Wulffraat NM, Rothova A, de Boer JH.
    Pathogenesis of juvenile idiopathic arthritis associated uveitis: the known and unknown.
    Surv Ophthalmol. 2014 September - October;59(5):517-531.
    http://www.ncbi.nlm.nih.gov/pubmed/25130893
 
AGOSTO 2014
 
JULIO 2014
  • Interlandi E, Leccese P, Olivieri I, Latanza L.
    Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
    Clin Exp Rheumatol. 2014 Jul 8. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25005224
  • Vastert SJ1, Bhat P, Goldstein DA.
    Pathophysiology of JIA-associated Uveitis.
    Ocul Immunol Inflamm. 2014 Jul 2:1-10. 
    http://www.ncbi.nlm.nih.gov/pubmed/24988139
  • Simonini G1, Katie D, Cimaz R, Macfarlane GJ, Jones GT.
    Current Evidence of Anti-TNFα treatment efficacy in childhood chronic uveitis: A systematic review and meta-analysis approach of individual drugs.
    Arthritis Care Res (Hoboken). 2014 July;66(7):1073-84 doi: 10.1002/acr.22214.
    http://www.ncbi.nlm.nih.gov/pubmed/24740981
  • Calandra S1, Gallo MC1, Consolaro A1, Pistorio A1, Lattanzi B1, Bovis F1, Muratore V1, De Marco R1, Martini A1, Ravelli A2.
    Female sex and oligoarthritis category are not risk factors for uveitis in italian children with juvenile idiopathic arthritis.
    J Rheumatol. 2014 Jul;41(7):1416-25. doi: 10.3899/jrheum.131494. Epub 2014 Jun 15.
    http://www.ncbi.nlm.nih.gov/pubmed/24931957
 
JUNIO 2014
 
MAYO 2014
  • Totan Y, Güler E, Guragaç FB, Dervisogullari MS, Tenlik A, Hepsen IF.
    Cystoid macular edema associated with juvenile idiopathic arthritis resolved by a dexamethasone intravitreal implant.
    J Pediatr Ophthalmol Strabismus. 2014 May 6;51:e25-8. doi: 10.3928/01913913-20140429-01.
    http://www.ncbi.nlm.nih.gov/pubmed/24811080
 
ABRIL 2014
  • Emmi G, Silvestri E, Ciucciarelli L, Squatrito D, Emmi L.
    Anti-IL1 blocking agents in drug-resistant Behçet's syndrome: our little case series.
    Clin Exp Rheumatol. 2014 Apr 7. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24709082
 
FEBRERO 2014
  • Pasadhika S, Rosenbaum JT.
    Update on the use of systemic biologic agents in the treatment of noninfectious uveitis.
    Biologics. 2014 Feb 15;8:67-81.
    http://www.ncbi.nlm.nih.gov/pubmed/24600203
  • Tugal-Tutkun 1, Quartier P, Bodaghi B.
    Disease of the Year: Juvenile Idiopathic Arthritis-associated Uveitis-Classification and Diagnostic Approach.
    Ocul Immunol Inflamm. 2014 Feb;22(1):56-63. doi: 10.3109/09273948.2013.871565. Epub 2014 Jan 10.
    http://www.ncbi.nlm.nih.gov/pubmed/24410427
  • Pålsson S, Nyström A, Sjödell L, Jakobsson G, Byhr E, Andersson Grönlund M, Zetterberg M.
    Combined Phacoemulsification, Primary Intraocular Lens Implantation, and Pars Plana Vitrectomy in Children with Uveitis.
    Ocul Immunol Inflamm. 2014 Feb 24. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24564567
  • Angeles-Han ST, Yeh S, Vogler LB.
    Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis.
    Int J Clin Rheumtol. 2013 Feb 1;8(1). doi: 10.2217/ijr.12.83.
    http://www.ncbi.nlm.nih.gov/pubmed/24187594
 
ENERO 2014
  • de Boer J, Steijaert A, van den Bor R, Stellato R, Ossewaarde-van Norel J.
    Development of Macular Edema and Impact on Visual Acuity in Uveitis Associated with Juvenile Idiopathic Arthritis.
    Ocul Immunol Inflamm. 2014 Jan 10. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24410459
 
DICIEMBRE 2013
  • Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Van Gelder RN.
    Expert Panel Recommendations for the Use of Anti-Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders.
    Ophthalmology. 2013 Dec 17. pii: S0161-6420(13)00893-2. doi: 10.1016/j.ophtha.2013.09.048. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24359625
  • Kotaniemi K, Sihto-Kauppi K, Salomaa P, Säilä H, Ristolainen L, Kauppi M.
    The frequency and outcome of uveitis in patients with newly diagnosed juvenile idiopathic arthritis in two 4-year cohorts from 1990-1993 and 2000-2003.
    Clin Exp Rheumatol. 2013 Dec 16. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24351424
  • Artornsombudh P, Pistilli M, Foster CS, Pujari SS, Gangaputra SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH.
    Factors Predictive of Remission of New-Onset Anterior Uveitis.
    Ophthalmology. 2013 Dec 14. pii: S0161-6420(13)00886-5. doi: 10.1016/j.ophtha.2013.09.041. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24342020
  • Angeles-Han ST, Pelajo CF, Vogler LB, Rouster-Stevens K, Kennedy C, Ponder L, McCracken C, Lopez-Benitez J, Drews-Botsch C, Prahalad S; CARRA Registry Investigators.
    Risk Markers of Juvenile Idiopathic Arthritis-associated Uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry.
    J Rheumatol. 2013 Dec;40(12):2088-96. doi: 10.3899/jrheum.130302. Epub 2013 Nov 1.
    http://www.ncbi.nlm.nih.gov/pubmed/24187099
 
OCTUBRE 2013
 
AGOSTO 2013
  • Lerman MA, Burnham JM, Chang PY, Daniel E, Foster CS, Hennessy S, Jabs DA, Joffe MM, Oktay Kaçmaz R, Levy-Clarke GA, Mills MD, Nussenblatt RB,Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH.
    Response of Pediatric Uveitis to Tumor Necrosis Factor-a Inhibitors.
    J Rheumatol. 2013 Aug;40(8):1394-1403.
 
JUNIO 2013
  • Zierhut M, Heiligenhaus A, deBoer J, Cunningham ET, Tugal-Tutkun I.
    Controversies in juvenile idiopathic arthritis-associated uveitis.
    Ocul Immunol Inflamm. 2013 Jun;21(3):167-79. doi: 10.3109/09273948.2013.800561.
    http://www.ncbi.nlm.nih.gov/pubmed/23713826
 
MAYO 2013
  • Papadopoulou C, Kostik M, Böhm M, Nieto-Gonzalez JC, Gonzalez-Fernandez MI, Pistorio A, Martini A, Ravelli A.
    Methotrexate Therapy May Prevent the Onset of Uveitis in Juvenile Idiopathic Arthritis.
    J Pediatr 2013 May 9. pii: S0022-3476(13)00323-5. doi: 10.1016/j.jpeds.2013.03.047. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23664559
  • Simonini G, Paudyal P, Jones GT, Cimaz R,Macfarlane GJ.
    Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach.
    Rheumatology 2013 May; 52:825-31.
    http://www.ncbi.nlm.nih.gov/pubmed/22879466
  • Sakai T, Watanabe H, Kuroyanagi K, Akiyama G, Okano K, Kohno H, Tsuneoka H.
    Health- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitis.
    Br J Ophthalmol. 2013; 97:338-42.
    http://www.ncbi.nlm.nih.gov/pubmed/23314623
 
ENERO 2013
  • Zannin ME, Birolo C, Gerloni VM, Miserocchi E, et al.
    Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry.
    J Rheumatol. 2013 Jan;40(1):74-9. doi: 10.3899/jrheum.120583.
 
OCTUBRE 2012
  • Gregory AC 2nd,Kempen JH,Daniel E et al.
    Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated with Juvenile Idiopathic Arthritis: The Systemic Immunosuppressive Therapy for Eye Diseases Study.
    Ophthalmology.2012 Oct 11. pii: S0161-6420(12)00687-2. doi: 10.1016/j.ophtha.2012.07.052. [Epub ahead of print].
    http://www.ncbi.nlm.nih.gov/pubmed/23062650
 
SEPTIEMBRE 2012
  • Heiligenhaus A, Foeldvari I, Edelsten C, Smith JR, Saurenmann RK, Bodaghi B, de Boer J, Graham E, Anton J, Kotaniemi K, Mackensen F, Minden K, Nielsen S, Rabinovich EC, Ramanan AV, Strand V; Multinational Interdisciplinary Working Group for Uveitis in Childhood.
    Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood.
    Arthritis Care Res (Hoboken). 2012 Sep;64(9):1365-72. doi: 10.1002/acr.21674.
    http://www.ncbi.nlm.nih.gov/pubmed/22438273
 
JUNIO 2012
  • Tappeiner C, Heinz C, Ganser G, Heiligenhaus A
    Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis?
    J Rheumatol. 2012 Jun;39(6):1294-5
    http://www.ncbi.nlm.nih.gov/pubmed/22661419
PATROCINADORES

Área de Socios